Compound Summary


budesonide
  Compound Information
 budesonide

Compound Name:

budesonide

Compound CID:

5281004

Synonyms:

budesonide

Pulmicort

Rhinocort

Entocort

51333-22-3

More...

Iupac Name:

(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one

InChI:

InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1

InChIKey:

VOVIALXJUBGFJZ-KWVAZRHASA-N

Canonical Smiles:

CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C

Isomeric Smiles:

CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C

Molecular Weight:

430.5

Molecular Formula:

C25H34O6

  Compound Structure
 2D Structure:
 3D Structure:
  Computed Properties
 budesonide

Molecular Weight:

430.5

Molecular Formula:

C25H34O6

Hydrogen Bond Donor Count:

2

Hydrogen Bond Acceptor Count:

6

Rotatable Bond Count:

4

Heavy Atom Count:

31

Complexity:

862

  Synonyms
 budesonide

budesonide budesonide

budesonide

Pulmicort

Rhinocort

Entocort

51333-22-3

Preferid

Rhinocort Aqua

Entocort EC

Pulmicort Respules

Budesonidum

Uceris

Budeson

Pulmicort Flexhaler

Cortivent

Micronyl

Respules

Spirocort

Bidien

S-1320

CHEBI:3207

MAP-0010

51372-29-3

MLS000028507

Budesonide MMX

Rhinocort alpha

(R)-Budesonide

16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione

(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione

Budenofalk

Budesonido

SMR000058337

Budecort Inhaler

(+)-16alpha,17alpha-Butylidenedioxy-11beta,21-dihydroxy-1,4-pregnadiene-3,20-dione

16A(R),17-(BUTYLIDENEBIS(OXY))-11B,21-DIHYDROXYPREGNA-1,4-DIENE-3,20-DIONE

Budesonidum INN-Latin

Budesonido INN-Spanish

Inflammide

Budiair

Miflonide

Pulmaxan

Fvolir

Budesonide USAN:INN:BAN:JAN

Rhinocort Allergy

Pulmaxan turbohaler

Pulmicort (TN)

Pulmicort Topinasal

Rhinocort (TN)

Pulmicort turbuhaler

Budesonide Easyhaler

S 1320

CCRIS 5230

Entocort EC (TN)

SR-01000000101

EINECS 257-139-7

Jorveza

Eltair

Ultesa

Noex

Giona Easyhaler

16?,17-(1RS)-Butylidenebis(oxy)-11?,21-dihydroxypregna-1,4-diene-3,20-dione

Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11.beta.,16.alpha.)-

Prestwick_840

MFCD00083259

Uceris (TN)

(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione

16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione

(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde

Budesonide, >=99%

Opera_ID_1696

Prestwick0_000518

Prestwick1_000518

Prestwick2_000518

Prestwick3_000518

Epitope ID:161750

B 7777

SCHEMBL4096

CHEMBL1370

Pregna-1,4-diene-3,20-dione,16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11beta,16alpha)-

Lopac0_000174

BSPBio_000475

Budesonide (JAN/USP/INN)

MLS001077323

MLS002207112

SPBio_002396

BPBio1_000523

GTPL7434

DTXSID8020202

HSDB 8279

MAP0010

R01AD05

HMS1569H17

HMS2096H17

HMS2232D17

HMS3259H07

HMS3260D09

HMS3413B08

HMS3413P17

HMS3677B08

HMS3677P17

HMS3713H17

ACT03247

BCP05589

Eohilia (budesonide oral suspension)

Tox21_500174

BDBM50354850

AKOS015969655

AC-4697

ACN-043365

CCG-204269

CS-2063

DB01222

KS-1162

LP00174

NC00626

NSC 757788

SDCCGSBI-0050162.P002

11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione

NCGC00021318-05

NCGC00021318-06

NCGC00021318-08

NCGC00021318-18

NCGC00089747-04

NCGC00260859-01

BB164267

Budesonide 100 microg/mL in Acetonitrile

CPD000058337

HY-13580

Pregna-1,4-diene-3,20-dione, 16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11-beta,16-alpha)-

Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione

B3909

EU-0100174

5301-EP2270008A1

5301-EP2280006A1

5301-EP2281563A1

5301-EP2281813A1

5301-EP2281815A1

5301-EP2281819A1

5301-EP2292617A1

5301-EP2292619A1

5301-EP2295402A2

5301-EP2295408A1

5301-EP2301933A1

5301-EP2305640A2

5301-EP2305659A1

5301-EP2308562A2

5301-EP2311818A1

5301-EP2311827A1

5301-EP2314590A1

5301-EP2316459A1

5301-EP2371811A2

D00246

T70986

333B223

Q422212

J-504150

Q-101375

SR-01000000101-2

SR-01000000101-6

BRD-A34299591-001-03-4

Budesonide, European Pharmacopoeia (EP) Reference Standard

Budesonide, United States Pharmacopeia (USP) Reference Standard

Budesonide, Pharmaceutical Secondary Standard; Certified Reference Material

(11?,16?)-16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione

(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo10.8.0.0^{2,9}.0^{4,8}.0^{13,18}icosa-14,17-dien-16-one

(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-6b-Glycoloyl-5-hydroxy-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho2,1:4,5indeno1,2-d1,3dioxol-2-one"

(6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho2,1:4,5indeno1,2-d1,3dioxol-4-one"

(6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho2,1:4,5indeno1,2-d1,3dioxol-4(2H)-one"

  Experimental Data
 budesonide

Species Dose Unit Control(Avg days) Treatment(Avg days) Avg/Med Lifespan Change(%) Control(Max days) Treatment(Max days) Max Lifespan Change(%) Significant Strain Gender PubMed Avg/Med Lifespan Change tab
Caenorhabditis elegans 33.000000000000000 umol/L -8.000000000000000 NS N2 24134630 Inactive
  Experimental Data Visualization
 budesonide

  Statistics Data
 budesonide

Species Avg/Med Lifespan Change(%) Max Lifespan Change(%) Count Reference Count Data point
Caenorhabditis elegans -8.000000000000000 1 1
  Statistics Data Visualization
 budesonide